Summary
bletabolic studies on two patients with defects in the tyrosine oxidation pathway are reportcd. S c r u n~ tyrosine was greatly elevated in both patients (1.37 and 1.52 n~mol/liter, respectively) and both excreted large quantities of p-hydroxyphenylacctic acid, p-hydroxyphenyllartic acid, and p-hydroxyphenylpyruvic acid. Deuterated tyrosine loads were administered to both patients, before and after lowering of the serum tyrosine concentration by dietary treatment, and to a normal adult control subject.
In one patient the excretion of the deuterated (D,)-tyrosine load was more than 300 tin~es that found in the control sul~ject whether the test was done at high or low serunl tyrosine level and the pattern of n~etabolites indicated a persistent defect in phydroxyphcnylpyruvic acid oxidase. Enzyme assays on needle liver biopsy supported this finding. In the second patient cxcretion of the D, label was 300 tin~es that of the control at high serum tyrosine levels, but only 5 t i r~~e s nornlal a t low serum tyrosine levels. This finding was interpreted as inclicating substrate inhibition of p-hydroxyphenylpyruvic acid oxidase. The prin~ary defect has not been established in this patient, but the findings are con~patible with a defect in hepatic-soluble tyrosinc aminotransfcrase.
Speculation
We have shown that loacling rates of 220 p n~o l deuterated tyrosinelkg bocly weight are adecluate for precise rneasuren~ent of the stable isotope content of urinary tyrosine and tyrosine metabolites. This load approximates that provided by a protein containing n~eal; therefore, stable isotope load studies can be clain~ed to I I I~I I I~C physiologic events.
Confusion exists in both terminology and basic understanding of metabolic diseases causing elevation of the serum tyrosine level. Transient neonatal tyrosincmia may reach remarkably high levels without any symptoms. On the other hand, the elevation of serum tyrosine is only moderate in those babies with tyrosinemia who present with serious hepatorenal disease. Among the published reports regarding tyrosinemia arc recorded eight older patients (including the two patients discussed here) who have very high serum tyrosine levels, but no evidence of liver or kidney disease (1, 5 , 12) . Mental retardation has been a prominent feature, as have eye and skin lesions. However, considerable hcterogcneity exists in the clinical features and biochemical findings. The term "nonhcpatic tyrosinernia" is uscd to indicate the absencc of liver damage in these patients-some havc usctl the term "tyrosinosis," but this has also bcen used in other contexts.
Both patients studierl in Melbourne havc been reported prcviously. Their clinical features were different, but initial biocheniical results were very similar. It was decided to study the mctabolism of these two patients using isotope labeling techniques.
The atlministration of radioactive isotopes is not without risk to human subjccts and is, thcrcfore, only rarely suitable for it1 vivo nictabolic studies. Substrates labeled with stable isotopes d o not have this disadvantage, although deuterated c o n~~o u n d s are known to produce tleletcrious biologic effects, as deuterium may be preferentially retained it1 vivo. The amounts of deutcriumlabeled tyrosine uscd in this study are not considered a health risk, as even complete isotope retention i l l vivo would increase the natural abundance of deuterium in the body by only less than 2 0 % .
The studies with deuterium-labeled substrates revealed striking differences between the two patients (a preliminary account of which has already bcen published (3)). The enzyme dcfect has been identified in one patient, but complete resolution in the other paticnt would necessitate surgical biopsy of the liver ancl this was not considered justified.
CASE REPORTS
Since both of these patients have been reportcd previously, only very brief clinical synopses arc provided here.
JL, a 35-year-old mcntally retarder1 male, has been an inmate of the Children's Training Centre, Kew, for most of his life. Nothing is known of his family history. His retardation is moderate, he is of relatively short stature (151.5 cm), and he has a marked tremor which is aggravated by attempts of finc manipulation. Earlier studies showed that the tremor was improved by a low tyrosine diet and was aggravated by the administration of L-3,4-dihydroxyphcnylalaninc (L-DOPA). He was othcrwise physically normal. The biochen~ical findings of earlier investigations were in close accord with those obtained in the prcscnt studies (12) .
PR, an 1 I-year-old girl at the time of investigation, harl been attending the Royal Children's Hospital since the age of 18 months because of recurring pscudohcrpctic keratitis and pcrsisting plantar and palmar hypcrkeratosis (Richter-Hanhart syndrome). Separate reports of these two features have been published at an earlier stage by other authors (1, 17) . She was FAULL referred for metabolic investigation after reports appeared linking this syndrome with tyrosincmia (5).
IIer growth had :always becn quite normal as had her general physical health. Her school performance was lagging behind expectations by about 1 year, but this had been attributed to her persisterlt eye discomfort ancl her repeated absence from school. flowever, formal psychornctric testing did indicate that hcr abilities were in the low normal range.
During the initial investigations deutcratcd tyrosine (829 pn~ollkg tyrosinc in total, 663 pmollkg D,-tyrosine) was administered to J L and PR but caused a persistent rise in the serum tyrosinc of only PR. Within an hour of administration of the load I'R complained of intense burning pain in her hands, feet, and cycs. During the ncxt 2 or 3 hr an acute inflammatory reaction developed around the hyperkcratotic lesions on the hands and fect. This took several days to subside. Ta,elvc hours after a low phenylalanine, low tyrosine diet was commenced PR excitedly announced that her hands, feet, and cycs felt comfortable for the first time in her memory. The cyc lesions healed co~npletcd within a week and the skin lesions gradually cleared over 4 or 5 months so that there is now no detectable abnormality on the closest inspection. The tlcrmal ridge pattern took almost 12 months to return to normal. PR has now becn rnaintaincd free of symptoms for 18 months on a diet based upon Alburnaid XPT (20) allowing 220 pmol phenylalaninc and 220 pniol tyrosinel kg124 hr. She has continued to grow normally and has caught up with her school work to some extent.
One of the authors, a healthy 43-year-old male, served as a control subject for the dcuteratcd tyrosine load study.
All serum and urine samples were frozen i~nmediately aftcr collection and were held at -20" until used for measurements. Urine samples for catecholamine analysis \\(ere acidified (10 nil 6 N HC1/2 liters urine) before freezing. Urinary crcatinine was determineel by thc Jaffe reaction. Quantitative results were means of cluplicate preparations.
UKINARY F K I E AKOhfA'I'IC AhtINO ACIDS 2-Aniino-11-octanoic acid (100 pg) was addcd as an internal standard to 1 ml urine and the solution was acidified to pH 2-3. The urine was then passed through a column of cation exchange resin (Bio-Rad A G 50W-X2, 100-200 mesh, 500 mg wet weight, H + form) and the column was washed with water. The amino acids werc eluted with aqueous ammonia (2 N) anel the eluate was dricd under vacuum (40").
The dried residue was derivatized for quantitative gas chromatography (GC) analysis by esterification under reflux (45 min, thionyl chloride-dry nletharlol rcagcnt ( l o % ) , 1 ~ml). After evaporation, derivatization was completed by the addition of dry pyridine ( 3 0 0 PI), pivalclehydc (50 pi), triethylaminc (100 pl), and ~nolecular sieve (type 5A). N,O-Bis(trinicthylsi1yl)trifluoroacctarnide (BSTFA) was addcd 30 rnin later (100 pl), and after standing for a further 30 min a sample was injcctcd onto the gas chromatograph (18) . The recovery of tyrosinc, phcnylalanine, p-tyramine, and 2-amino-11-octanoic acid by the above proccdure was chccked by extracting samples of urine spiked with known amounts of each of these compounds and derivatizing the extract. The percentage of recovery of each amino acid exceeded 95% as determined by G C using a peak height mcasurenlcnt.
A part of thc dricd amino acid residue was derivatized for nleasurenlent of the dcuteriu~n content of tyrosine by treatment with trimethylanilinium hydroxide in anhydrous n~ethanol (100 pl, 0.1 N) and pivaldchyde (10 pl) , in the presence of niolecular sieve (type 3A), and pyrolytically estcrifying the salt in the injector port of the gas chromatograph prior to GC-mass spectrometry (MS) analysis (19) . UKINARY CONJUGATED AKOhlATIC AhllNO ACIDS . .
Ihe method usecl was basccl on that described by Kakimoto and Armstrong (7) in which the initial cffluent ancl \vashings from the cation exchange resin were collcctcd and hydrolyzed in 6 N HC1 at 100 'for 3 hr after the acldition of 100 p g 2-amino-11-octanoic acid ;IS internal standard. Thc hydrolysates were clrictl under vacuum (40") and were then extr:actcd and dcrivatized for G C analysis in the same manner as described for the free amino acids.
The rccovery of N-acctyltyrosine andp-tyraminc was checked as before by spiking urinc samples with thesc compounds. I n these cxpcrirnents N-acetyltyrosine was addcd to the urine before the initial ion exchange treatment, whereasp-tyraminc was added to the urine imrncdiatcly before hyclrolysis. Thc pcrcentage of recovery of thcsc two compounds exceeded 9 0 % as clctcr~nincd by G C (peak height).
For mcasurernent of the deuterium content of serum tyrosinc, samplcs (100 p1) wcre cleprotcinizcd by :addition of ethanol (400 pl) and centrifugation, aftcr which the supernatant was drawn off and evaporated with nitrogen. 'I'hc dried rcsidue was clcrivatized as described under "Urinary Free Aromatic Amino Acids."
Serum tyrosine concentration was measured colori~nctrically by the method of Udcnfricnd and Cooper (16) in which 0.5 ml 30% trichloroacetic acid was added to 0.5 ml serum which had bccn diluted with 1.5 ml watcr. ?'he mixture was allowetl to stand for 10 min and was thcn centrifuged; 1.0 rnl of the supcrnatcnt was ;adclcd to 0 . 5 mi of I-nitroso-2-n;1pl1tliol reagent (0.1 % in 9 5 % ethanol) to \vhich was then addcd 0.5 ml of nitric acid reagent (0.5 mg sodium nitrite in 1.0 ml of 2 0 % ;aclucous nitric acid). The solution was stoppereel and, aftcr heating in a water bath at 55' for 30 mill, 5 ml of rcclistillcd ethylene clichloricle ivcrc addcd. Thc mixture was thcn slinken and ccntrifuged at low spcccl, and the optical clensity of the top layer was read at 450 nm.
URINARY PtlENOLIC ACIDS
Adipic acid (100 pg) was addcd as an internal standard to 1 ml urine and the solution was acidified to pH 1 with 0.1 ml 6 N IICI; 2 nil saturated aqueous NaCl wcre thcn added. The mixture was extracted with ethylacctatc (3 x 2 ml), and the organic cxtracts were pooled and dried over anhydrous rn:igncsiurn sulfate. After filtering, the solution was evaporated to dryness with dry nitrogen. 'The dricd residue was dcrivatized for G C analysis with BSTFA (100 pl) followed by heating to 70'" for 30 miri (4) .
To ensure quantative recoveries of organic acids, urine extracts were prepared as quickly as possible aftcr collection. However, circumstances caused some samples to be held at -20" for several weeks before extraction. G C response factors were dctcrmined using authentic compounds (21) which had bccn stored at -20". The recovery of p-hydroxyphcnylacetic acid (PHPAA), p-hydroxyphcnyllactic acid (PIIPLA), p-hydroxyphenylpyruvic acid (PHPPA), and adipic acid froni urinc was checked as before by spiking urinc samples with known amounts of each compound. Recoveries exceeded 95% and werc detcrmined by G C peak height measurements of the tri~nethylsilyl derivatives.
GAS CHROhfATOGRAPlfY
This was carried out on a Packard-Becker 419 gas chromatograph using a glass column (6 fect x 0.25 inch) packed with 3 % Apiezon N on dimethyldichlorosilane-trcated Chromasorb W . A nitrogen flow ratc of 25 ml/min was used, and during the analy--scs thc temperature was progmmmcd from 100" to 250" at a ratc of 6"lrnin.
The identification of urinary metabolites \\,as confirmctl by combined GC-MS. T\vo GC-hlS machines \\.ere available for this work; the first was an Aerograph HiFy (60011) G C interfaced, via 3 Watso~i-Bieril;~~in separator, to a computer-opcratal EAI (300D) quatlrupolc niass spectrometer. The second was a Varian Aerograph (2700) GC, interfaced via a jet separator to a Dupont 491B rn;.ignetic sector mass spcctronieter fitted \vith a dual electron ion~zationlchcniic:~l ionization source.
h1EASURl:hlENT OF 1)EUTERIUhl CONTENT hleasurcnlcnt of tlic dcutcriu~n content of PIIPAA, PIIPI-A, 1' 1 II'I'A ;tnd tyrosinc was lnaclc during GC-hlS by cx;tmilling each mass spectruln and selecting an intense ion contairling the deuterium label. bleasuremcnt of the rclativc intensities of the nondcuteratccl (D,,), monodcutcratcd (Dl), and dideutcr:~ted (D,) peaks were then made or1 this ion. Initially, short rn;~nual scans across limited mass ranges were taken, and the peak heights were rncasurcd by hand. The precision of isotope mcasurcment was greatly improved by programming the quatlrupole mass spectrometer to operate in a mass fragmcntornctry mode with settings optimized for isotope measurement. With the rapid automatic scan it \\,as possible to accumulate many mcasurcrnents of relative peak heights from \vliich nican values were cr~lculatcd. The results were expressed as the percentage of the deuterated species represented of the total (D, x 100/(D,, + Dl + D,)), and a correction was nladc for the intensity of the 11, satclitc ion in the nondeutcratcd compound. The quantity of recovcretl cleuteratcd tyrosinc or dcutcrated tyrosinc mct:~bo-lite, in ~nicrornolcs per kg body weight or in micromoles per liter of serum, was then calcul;~tctl by multiplying the percentage of ~leutcrium label by the amount of metabolite present in the sample.
'I'nblc 1 lists the ion fragments of tyrosinc anrl tyrosine mctaholites used for clcuteriu~n mcasurcments.
L-Tyrosine (7 g) was retluscd for 4 lir in 4 N I)CI in I1,O (40 ml), and after cooling to Oo, the tyrosinc \\,as precipitatccl by adjusting the solution to a pfl of 5.5 with ammonia. l'he p~c i p itatc was collcctctl by filtration and the tyrosine crystallizccl from a minimal clu:~ntity of boiling water. The crystals were filtcrcd off, waslieti with ethanol, ancl dried in a clcssicator. 'Ilic identity of the product \+#:IS confirmed by mass spectrolnctry as tyrosinc containing 2 deuterium atoms in the tropyliuni ion (m/e 93). The positions of the clc~ltcrium atoms in the aromatic ring were both s h o~v~i to be ortho to the phctiolic hydroxyl function by nuclear magnetic resonance (13) . I n n control experiment extending over ;I 24-hr period the deuterium lahcl \\.as slio\vn to be stahlc in acid nicdia (1 N IICI) at 38'. The dcutcratcd tyrosine suhstrate used for the lo:~tling studies consisted (IS 8 0 % clideutcratcd spccics (D,-tyrosine) 19% rmonodcutcratcd spccics. ant1 1 % unlabclcd tyrosinc. (6) . The rcaction misturc (RhI,. 0.9 ml) cont:iincd L-tyrosine (5.6 priiol), potassiuui phosphate buffcr. pl I 7 .h (1 00 pmol). trketoglutaratc (I 0 pnlol). pyridos;1l-5-phosphatc (0.05 pmol). ant1 L-I1'Cltyrosinc (7.5 pCi). Aftcr a 5-niin prcincubatio~i at 37' the rcaction was started by addition of tyrosinc aminotransfcrasc (0.1 ml. 2.5 mg/ml, purified os described by Granner and Tomkiris ( 0 ) and incubated at 37" for 5 min. Stcp 7 was the assay of PIII'I'A osiclnsc in \\hich the rcaction rnisturc (Rb1,.0.3 ml) contained potassium pliospliatc buffer. p t l 0.3 (25 pmol). ascorbic acid (1 pmol), cr.n-dipyritlyl ( 0 . 8 pmol). and glut;~tliionc Rcfcrs to the intensity of cach fr;~gmcnt ion (D,,) as a percentage of the most intense ion in cach mass spcctrum.
reaction \\.as stopped by ;~cldition of trichloroacctic acid (I 0 % . 0.1 ml). A blank \\#as run \\,it11 trichloroacctic acid ;~clclcd to R h l , before incubation. Aftcr freezing tlie supernatants (100 PI) \\,ere cliromntogr:~plicd on Whatnian SGH I ( 4 0 hr) o r 3hIhZ (1 6 hr) wit11 watersaturated ti-hutarlol containing 0.1 % formic acid (9) . This allo\vcd s c p~~r a t i o n of liomogcntisic acid from tyrosinc and P H P P A . Homogcntisic acid side marker \\.as tlctectcd by staining \vith ammoni:~cal silver nitrate (9) . and the chrorn:~togr:~m \\.as run in tlic second dinicnsion in water ( 3 hr). T h e liomoge~i-tisic acid spot was then located \\.it11 amrnoni:~cal silver nitrate.
and tllis \\.as cut into 2.6-x I .')-ern rcct:~nglcs for radio:ictivc counting. The results arc cxprcsscd :IS raclio:~cti\~c counts in liomogcntisic acid per 2 0 min per mg protein.
13IOCIlI7hllCAL AI3NOIIhlALI'I'IES 0 1 . ' I'ATIENTS
Initial bioclicniical findings on an unrcstrictccl diet arc listed in Table 2 . Scruni tyrosinc \\,:IS grossly increased and both excreted ninssivc amounts of p-liydroxyphenolic acids. Excretion of Nncctyltyrosinc was increr~scd. Neither patient had any evidence of liver o r kitlncy disc:~sc. :~ncl serum and urinary levels of mctliioniric wcrc normiil. The amounts of free and conjugatcdptyraniinc in 1-1111 saniplcs of urinc from hot11 paticnts wcrc l)elo\v the limits of clctcction by GC-h1S.
In the initial studies, performed o n tlic t\vo paticnts before any dietary tr.catlncI11 \ \ a s give11 and OII t l~c 1lor111;1l control subject. c:~cIi subject ingested 6 6 3 prnol D,-tyrosinelkg body ~c i g l i t after an 8-lir fast. 'l'lic tyrosinc \\.as dissolved wit11 the niininium aciclification necessary to acliicvc solubility in approxirn:~tcly 100 nil water. Toast and a fruit juicc drink were allowed long \\.it11 the load. The stucly of I' IZ \\.;IS pcrfornicd first :~rld \\,as continued for only 24 lir. Aftcr cxarniriing the rcsults all other stuclics were continuccl for 4X hr. T h e tot;~l recovery of the two tlcutcrium labels in the phenolic ring of tyrosinc rid tyrosinc rlictal)olitcs (licnccfortli rcfcrrctl to :IS the D,-plicnolic moiety) in the urinc of the tlircc subjects is sumniarizc(l in 7';1bIe 3 . 7'lle total rccovcry \\.:IS much greater in t l~c t\\,o paticnts than in the control subject. All tlircc p-1i)~droxypIicnolic acids wcrc present and were h c~~v i l y labeled in tlic paticnts. but only I'IiPAA was present aricl contained signific;~nt 1;ibcling in the control. Detailed consitlcr:~tion of tliesc results is prcsentcd later after allo\\,ing for diffcrcnccs in tyrosinc pools.
The urinary output of cleuter:~ted catccliolaniines, i . e . , 3,4-tlihytlroxyplicnylethylarni~ic (iiopa~liinc), arlrenalin, :ind noradrerlalin, wcrc also tlctermined by GC-ILIS using tlie volatile Ntrifluoro:~cctyI-O-trimcthylsilyl tlcrivatives of these compountls, but because of the rel:~tivcly sm:~ll total procluction of these metabolites, the results have not been includcci ill this table a s they account for less than 0.1 Cb of the total recovery in the urinc of the 11,-phenolic moiety. The urinary output o f tleuter:~tctl Nacetyltyrosi~ic was not rlctcrminctl because the rcl:~tivcly sniall total production of this metabolite would account for less than 376 of tlic total recovery in the urinc of tlic D,-phenolic moiety.
Another clifference bct\vcen the control ancl J L is apparent in Table 3 . 'l'lie control subject excreted tlie vast nlajority of the recovcrecl 1:tbcl in the first 24 hr and very little in tlie next clay. The total serum tyrosine concentration and the conccntration of D,-tyrosine in the serum were both measured. The total tyrosine concentration rose to very high levels indeed in PR and were still not back to preload levels 7 days later. The rises observed in J L and in the control were smaller and more transient (Fig. 1, B and D) .
The initial rate of appearance of D,-tyrosine in the scrum was very similar in all three subjects, but both patients differed from the control subject in that the D,-tyrosi~lc concentration continued to rise up to 8 1ir aftcr the loarl (Fig. 1, A ant1 C) .
All of these results inclicnted striking tliffcrences between the paticnts and the norrnal control subject, but less impressive differc~lces between the two paticnts.
Dl-TYROSINE LOAD TEST A R E R DIETARY CONTROL
A rernarkable difference in the tyrosinc metabolism of the two patients became apparent after a second series of experiments performed aftcr the serum tyrosine conccntration had been lowered through restriction of the dietary intake of phenylalaninc and tyrosine. A smaller load of D,-tyrosinc (221 pnol/kg body weight) was used.
The total recovery of the D,-phenolic moiety in the urine of the two patients in this series of experiments is shown in Table 4 . The results in J L are very similar to those of the original test, but the handling of the labeled tyrosinc has changed to nearly normal in P R .
A summary of the recovery results from the five experiments with D,-tyrosine loads is given in Table 5 . Comparisons of the raw data of recovery o f label between the subjects in the two series of experiments are confounded to some extent by differences in serum tyrosine pool sizes. In Table 5 the data has been transformed by correcting for the initial serum tyrosine concentration (indicating the tyrosinc pool), allowing a more valicl comparison of the five studies. This comparison clearly shows that J L metabolized the label poorly at high or low serum tyrosine levels. However, the disposal of label in PR iniproved dramatically when the serum tyrosine level was lowered.
Mcasurenlcnt of the conccntration of D,-tyrosinc in the scrum of the paticnts after the second oral load of D,-tyrosine is shown Changes in scrum tyrosinc concentration and scrum deuteratcd tyrosinc conccntration in pnric,tlrs JL. and PR, before and after dietary treatment, and in a normal control subject, after oral loads of dcutcratcd tyrosine.*: because no scrum samplcs wcrc collcctcd during this timc period these points have not been connected by a continuous line. Figure 1 , A and C, and changes in total serum tyrosine concentration arc shown in Figure 1 , B and D . Once again JL's rcsults followed a pattern similar to the previous study, wlicrcas the pattern in Pli approximates that obtained in the control subject.
ENZYhlE ASSAY RESULTS
'l'hc results of the enzyme assays performed o n needle biopsy samples are shown in Table 6 . The small amount of tissue available (15-20 mg) limited the precision of the assay as cxperirnents could not be repeated for confirmation of rcsults. The PHPPA oxidase assay gave no result in PR and there was no tissue available to repeat the test. The two chron~atographic systcms gave different results in J L . There was no doubt that the spot counted 011 SG81 was homogentisic acid. It is more difficult to guarantee separation of homogcntisic acid from all othcr radioactive prescursors or products. Consequently, the results are interpreted as showing severe deficiency of enzyme activity.
The tyrosine aminotransferase assay sho\red definite activity in both patients which was quantitated only in J L .
DISCUSSION
In con~paring the results of D,-tyrosinc loading in the paticnts and in the normal control subject it seems reasonable to assume that disposal of tyrosine in protein synthesis and in conversion to thyroxine, melanin, and catecholarnines is fairly constant and that the differences observed reflect mainly the variation in oxidation of the tyrosine carbon skeleton.
Excretion of the intact D2-phenolic moiety was grossly excessive in both patients when tested before dietary treatment, indicating a marked impairment of the oxidative pathway. This situation persisted aftcr lowering the serum tyrosinc by dietary m a n s in J L and it was not surprising to find low levels of PHPPA oxidase in his liver biopsy. The rcsults obtained using the two different chromatography systems did not agree very satisfactorily. However, spurious increase in the result (because of failure to separate homogentisic acid from some othcr labeled metabolite) is more probable than a falsely low result.
The dramatic change observed in the effect of D2-tyrosine load after lowering of the serunl tyrosine in I ' l i suggests that the high initial serum tyrosine level was inhibiting the function of PHPPA oxidase in vivo. Unfortunately, the enzyme assay performed on the needle liver biopsy did not succeed in definitely ruling out an intrinsic defect in this enzyme. An alternate proposal might be the existence of a genetic defect in PHPPA oxidase with a degree of rcsitlual activity ivliich is subst;tntially grcatcr than tIi;tt present in J L . Ur~tIcr such ;I circ~lr~ist;trice tlicrc might be a tliffcrcncc in the h;lndling of D, lo;~d ;tt diffcrcnt scrum tyrosinc Icvcls. 'flie fact that tlie second lo:td test was performed wit11 a l o~v c r loacl might p;lrticul:trly suggest tliis explanation. llo\vcvcr, it must be remcmberetl that the same lower load \v;~s usccl \vhcrl testing JL after tlict:try treatment and tli:tt the results in T:~ble 5 arc correctctl for tyrosinc pool size.
Tlic present tlitta canrlot absolutely distinguish hcttvccn thcsc two possibilities, but tlic tlcgrcc of change seems more cotiipatiblc with the suggcstioli of substrate inhibition. The extraortlin:trily slow dispos;ll of the initial 11,-tyrosinc load by I'R (the D,-tyrositlc was still cletcctahle iri her scrum after 7 days) sccrns incornp;ttiblc with the suggestion of a mild constant tlcfcct in 1'1-1PPA oxiclasc. PIIPPA osidasc Iias bee11 shown to be susccptiI>lc to substr:ttc inhihition itr i.i/ro (10. 11). Scrivcr (15) has already postulntcrl substr;~tc inhibition to csplain the accumulation of hoth the metabolic proclucts ancl the substrate of the ilcfcctivc cnzyrnc in n patient wit11 tlcficient hepittic cytosol tyrosinc aminotransfer;ise tlcscrihcd by Kcnnaway and Buist (8) . 71'liis pitticnt suffered skin and eye Icsions i~lcnticr~l to those present iri PR. 'l'hc matter can only be finally resolved by a t1cuter:tted load test in Kcnnaway ancl Buist's patient, o r by a riiore s:ttisfactory cnzyrnc assay in I'R. A D,-tyrosine lo:id givcn to a nornial control subject at high serum tyrosinc levels might ;tchicvc the sanic end but there is no easy method of achieving n consistent tyrosinc levcl of the nl;tgnitudc necessary in a riorriial corltrol subject.
If substrate inhibition is truly the explanation in tliis patient it is most intcrcstirlg to note the severe dcgrcc of metabolic block producccl hy this second;lry effect compared to the rattler minor intcrfcrcrlcc with tyrosinc dispos;tl ;ipparcntly attributable to the basic cnzyme defect.
TIic negligible formation of deutcratccl N-acetyltyrosinc and dcuteratcd p-tyraminc in both patients contrasts with findings in sonic of the previously tlcscribccl c:~scs (see Rcference 5) and with a recent cl;lim that this becomes the major pathway of disposal of tyrosinc under circurnstaticcs of high loacl in tiiicc (2) .
O n e shoultl not be too surprised by clifferences in byproclucts of ;~ccuriiulating tiietabolitcs in cliffcrent patients with the s:lmc basic nlctabolic block for genetic Iieterogcrieity is great in normal hurn:tns ant1 must c;tuse cliffcrcnces in the capacity of these minor p:ttIi\v:lys.
The ~x~t t c r t i of ;~c~~~n~~l ; t t i r i g ~iict;tbolic proilucts was very similar in JL and Pli, yet the b:~sic lesion provccl to hc vcry iliffcrclit. JL tlitl cxcrctc greater amounts of PlII'I'A than PR I>ut \vc arc loathe to place great significarlcc or1 the fortiier without extensive investigation of tlie rate of clicriiical convcrsiorl of PIIPPA to I'HPAA and PlIPLA urldcr the conditiolls o f storage. O n e rnight hope that the results in tlicsc patients ant1 the points just discussed tn;iy deter those w h o ilnaginc that they can resolve the mctaholic tlefcct in Grace htctles' classic patient (14) retrospectively .
O n tlic other hand, tlie incrcasetl lcvcls of DOI'A and tlopa111inc tnay be responsible for the tremor \vliich was a rnajor symptom in JL. Administration of L-IIOPA incre:~scd rhc trcmor (13) ; t r i~I tlic trcr~ior ~l i r~i i r~i~h c d \VIICII tlic scrurli tyrosinc level \\,as lowcrccl by dietilry nlc;lns cluririg this study. -1'hc precise cause of the mental retardation which has beer1 a prominent feature of most of the rcportetl patients is not clear arlrl i t is impossible to prctlict \vllctllcr early dietary treatment \voultl prevent this def~:ct. F-Iowcvcr, the relationship bet\vecn serum tyrosinc levels and the skin and eye Icsions \vas very direct in I'R. Elevation of the scrum levcl causctl an acute increase in the Icsions and the p:tili in them was abolishetl vcry rapidly when the diet was stltrted.
CONCLUSION
hlctnbolic stutlics on t~o paticnts with rare forms of nonhcpittic tyrositlcrnia. using dcutcratcd tyrosinc loads. resolved an anomalous situation in \vliich the two patients 1i;tcl diffcrcnt clinical symptoms but similar biochemical nbnorni;~lities.
O n e patient. an institution;ilizcd nicnt:llly retarded nialc wlio had a rn~trkcd tremor of the head. hands. and feet. \vas found to be suffering from a dcfectivc 11-hydroxyphenylpyruvic acid oxid:~se system. The results of enzyme ;issays o n needle liver h i o p sics \\.ere not very satisfactory. but did support this finding. In this patient urinary excretion of tyrosine. and p:trticularly the phenolic metabolites of tyrosinc. \\.as grossly elevrtted. Although this situation persisted after dietary treatment. some improvement in his bchavior \\.:IS noticed. particularly with respect to the loss of tremor.
The other patient, an I I-year-old girl of low normal intelligence with chronic palmar and plantar keratosis and recurrent pseudoherpetic keratitis, suffered from substrate inhibition o f phydroxyphenylpyruvic acid oxidasc when on a normal diet. Rcsolution of thc clinical and biochemical symptoms and disappcarance of the inhibition of p-hydroxyphcnylpyruvic acid oxidase occurred after adn~inistration of a diet low in phcnylalaninc and tyrosinc. The fundamental n~etabolic defect in this pnticnt has not been established. but the findings appcar compatible with a defect in hepatic soluble tyrosinc aniinotransferase.
